IRMD
Price
$61.80
Change
+$0.26 (+0.42%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
557.04M
28 days until earnings call
MASS
Price
$6.65
Change
+$0.04 (+0.61%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
227.41M
40 days until earnings call
Interact to see
Advertisement

IRMD vs MASS

Header iconIRMD vs MASS Comparison
Open Charts IRMD vs MASSBanner chart's image
iRadimed
Price$61.80
Change+$0.26 (+0.42%)
Volume$1.72K
Capitalization557.04M
908 Devices
Price$6.65
Change+$0.04 (+0.61%)
Volume$19.81K
Capitalization227.41M
IRMD vs MASS Comparison Chart in %
Loading...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRMD vs. MASS commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRMD is a StrongBuy and MASS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (IRMD: $61.53 vs. MASS: $6.61)
Brand notoriety: IRMD and MASS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IRMD: 158% vs. MASS: 83%
Market capitalization -- IRMD: $557.04M vs. MASS: $227.41M
IRMD [@Medical Specialties] is valued at $557.04M. MASS’s [@Medical Specialties] market capitalization is $227.41M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRMD’s FA Score shows that 3 FA rating(s) are green whileMASS’s FA Score has 0 green FA rating(s).

  • IRMD’s FA Score: 3 green, 2 red.
  • MASS’s FA Score: 0 green, 5 red.
According to our system of comparison, IRMD is a better buy in the long-term than MASS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRMD’s TA Score shows that 5 TA indicator(s) are bullish while MASS’s TA Score has 3 bullish TA indicator(s).

  • IRMD’s TA Score: 5 bullish, 5 bearish.
  • MASS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IRMD is a better buy in the short-term than MASS.

Price Growth

IRMD (@Medical Specialties) experienced а +1.87% price change this week, while MASS (@Medical Specialties) price change was -0.23% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.27%. For the same industry, the average monthly price growth was +1.95%, and the average quarterly price growth was -0.21%.

Reported Earning Dates

IRMD is expected to report earnings on Jul 31, 2025.

MASS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (+2.27% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRMD($557M) has a higher market cap than MASS($227M). MASS YTD gains are higher at: 200.227 vs. IRMD (12.565). IRMD has higher annual earnings (EBITDA): 20.8M vs. MASS (-34.03M). MASS has more cash in the bank: 146M vs. IRMD (49.8M). IRMD has less debt than MASS: IRMD (2.04M) vs MASS (5.95M). IRMD has higher revenues than MASS: IRMD (65.6M) vs MASS (50.2M).
IRMDMASSIRMD / MASS
Capitalization557M227M245%
EBITDA20.8M-34.03M-61%
Gain YTD12.565200.2276%
P/E Ratio31.84N/A-
Revenue65.6M50.2M131%
Total Cash49.8M146M34%
Total Debt2.04M5.95M34%
FUNDAMENTALS RATINGS
IRMD: Fundamental Ratings
IRMD
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
PROFIT vs RISK RATING
1..100
26
SMR RATING
1..100
41
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
26
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IRMDMASS
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 16 days ago
79%
Declines
ODDS (%)
Bearish Trend 21 days ago
58%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QLSGX28.550.24
+0.85%
Federated Hermes MDT Small Cap Growth R6
REDWX18.260.02
+0.11%
GreenFi Redwood Fund
PHSZX41.35N/A
N/A
PGIM Jennison Health Sciences Z
FVALX5.80N/A
N/A
Forester Value N
FERGX15.70N/A
N/A
Fidelity SAI Emerging Markets Index

IRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with HBIO. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then HBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
+1.69%
HBIO - IRMD
53%
Loosely correlated
+2.90%
ICUI - IRMD
45%
Loosely correlated
+0.84%
VREX - IRMD
45%
Loosely correlated
+1.75%
ITGR - IRMD
44%
Loosely correlated
-0.08%
TWST - IRMD
43%
Loosely correlated
+2.53%
More